title: [Cicatricial small intestinal stenosis following chemotherapy for a gastrointestinal lymphoma].
abstract: METHODS
  4 weeks after completing a course of chemotherapy for non-Hodgkin lymphoma of the jejunum a 45-year-old woman developed pain in the left upper abdomen and postprandial vomiting so that she could no longer take food by mouth.
  
  
  METHODS
  On admission she looked cachectic and had obviously lost weight. Plain abdominal X-ray gave no evidence of perforation or ileus. Gastroduodenoscopy showed no local recurrence. But contrast jejunal radiography (after Sellink) demonstrated two severe band-like stenoses of the jejunum with prestenotic dilatation. As she had not had any previous operation or radiotherapy, cicatricial stenosis was considered as the most likely cause. As the symptoms continued and stenosing local recurrence could not be excluded, surgical resection was indicated.
  
  
  METHODS
  Two cicatricial intramural stenoses of the proximal jejunum were found and histologically confirmed without evidence of lymphoma recurrence. After the operation the patient was again able to take food by mouth without problem. Follow-up examination 8 months later showed no recurrence and she was free of gastrointestinal symptoms.
  
  
  CONCLUSIONS
  After chemotherapy for gastrointestinal lymphoma obstruction of the small intestine may occur due to chemotherapy-induced scarring.
authors.affiliation: Radiologische Klinik, Universität Heidelberg.
authors.forename: M
authors.initials: M
authors.lastname: Libicher
authors.forename: W
authors.initials: W
authors.lastname: Lamade
authors.forename: C
authors.initials: C
authors.lastname: Kasperk
authors.forename: L
authors.initials: L
authors.lastname: Grenacher
authors.forename: G W
authors.initials: GW
authors.lastname: Kauffmann
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002921:Cicatrix / Q000139:chemically induced* / Q000150:complications; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D007415:Intestinal Obstruction / Q000209:etiology* / Q000601:surgery; D007579:Jejunal Diseases / Q000209:etiology* / Q000601:surgery; D007580:Jejunal Neoplasms / Q000188:drug therapy*; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
vernacular_title: Narbige Dünndarmstenose nach Chemotherapie eines gastrointestinalen Lymphoms.